Manage your account, request prescriptions, set up appointments & more.

Don't have an account
Contact Us


Transplantation Publication Citations

Arranged chronologically descending and alphabetically by lead author

Bennett WM.
Peritransplant management of retained native kidneys in autosomal dominant polycystic kidney disease.
Nephrol Dial Transplant. 2012 Jul 6. [Epub ahead of print]

Bennett WM, McEvoy KM.
A new system for kidney allocation: the devil is in the details.
Clin J Am Soc Nephrol. 2011 Sep;6(9):2308-9. Epub 2011 Aug 4.

Bennett WM, McEvoy KM, Henell KR, Pidikiti S, Douzdjian V, Batiuk T.
Kidney transplantation in the morbidly obese: complicated but still better than dialysis.
Clin Transplant. 2010 Oct 14.  [Epub ahead of print]

Bennett WM, Nespral JF, Rosson MW, McEvoy KM.
Use of organs for transplantation from a donor with primary meningoencephalitis due to Naegleria fowleri.
Am J Transplant. 2008 Jun;8(6):1334-5.

El-Sayegh S, Sayegh MH, Bennett WM.
Renal Transplantation: What's New?
Clin J Am Soc Nephrol. 2008 Jul;3(4):938-940.

Bennett WM.
Renal transplantation for ADPKD patients: a 2007 update.
Nephrol News Issues. 2007 Mar;21(4):24-5, 27.

Bennett WM.
Should dialysis patients ever receive warfarin and for what reasons?
Clin J Am Soc Nephrol. 2006 Nov;1(6):1357-9. Epub 2006 Sep 27.

Bennett WM.
V2 Receptor Antagonists in Cystic Kidney Diseases: An Exciting Step towards a Practical Treatment.
J Am Soc Nephrol. 2005 Apr;16:838-9.

Bennett WM, Hansen KS, Houghton DC, McEvoy KM.
Disseminated Intravascular Coagulation (DIC) in a Kidney Donor Associated with Transient Recipient DIC.
Am J Transplant. 2005 Feb;5(2):412-4

Bennett WM, McEvoy KM, Henell KR, Valente JF, Douzdjian V.
Morbid obesity does not preclude successful renal transplantation.
Clin Transplant. 2004 Feb;18(1):89-93.

Bustami RT, Ojo AO, Wolfe RA, Merion RM, Bennett WM, McDiarmid SV, Leichtman AB, Held PJ, Port FK.
Immunosuppression and the Risk of Post-Transplant Malignancy Among Cadaveric First Kidney Transplant Recipients.
Am J Transplant. 2004 Jan; 4(1): 87-93.

Shihab FS, Bennett WM, Yi H, Choi SO, Andoh TF.
Combination therapy with sirolimus and mycophenolate mofetil: effects on the kidney and on transforming growth factor-beta1.
Transplantation. 2004 Mar 15;77(5):683-686.

Shihab FS, Bennett WM, Yi H, Choi SO, Andoh TF.
Sirolimus increases transforming growth factor-beta1 expression and potentiates chronic cyclosporine nephrotoxicity.
Kidney Int. 2004 Apr;65(4):1262-71.
Bennett WM.
Immunosuppression with mycophenolic Acid: one size does not fit all.
J Am Soc Nephrol. 2003 Sep;14(9):2414-6.

Shihab FS, Bennett WM, Isaac J, Yi H, Andoh TF.
Nitric oxide modulates vascular endothelial growth factor and receptors in chronic cyclosporine nephrotoxicity.
Kidney Int 2003 Feb;63(2):522-33.

Shihab FS, Bennett WM, Yi H, Andoh TF.
Pirfenidone treatment decreases transforming growth factor-beta1 and matrix proteins and ameliorates fibrosis in chronic cyclosporine nephrotoxicity.
Am J Transplant 2002 Feb;2(2):111-9.

Yang CW, Faulkner GR, Wahba IM, Christianson TA, Bagby GC, Jin DC, Abboud HE, Andoh TF, Bennett WM.
Expression of apoptosis-related genes in chronic cyclosporine nephrotoxicity in mice.
Am J Transplant 2002 May;2(5):391-9.

Shihab FS, Bennett WM, Isaac J, Yi H, Andoh TF.
Angiotensin II regulation of vascular endothelial growth factor and receptors Flt-1 and KDR/Flk-1 in cyclosporine nephrotoxicity.
Kidney Int 2002 Aug;62(2):422-33.

Andoh TF; Johnson RJ; Lam T; Bennett WM.
Subclinical renal injury induced by transient cyclosporine exposure is associated with salt-sensitive hypertension.
Am J Transplantation 2001; 1: 222-7.

Bennett WM.
Divided loyalties: relationships between nephrologists and industry.
Am J Kidney Dis 2001; 37: 210-221.

Kang DH; Kim YG; Andoh TF; Gordon KL; Suga S; Bennett W et al.
Post-cyclosporine-mediated hypertension and nephropathy: amelioration by vascular endothelial growth factor.
Am J Physiol Renal Physiol 2001; 280: F727-36.
Olyaei AJ; de Mattos AM; Bennett WM.
Nephrotoxicity of immunosuppressive drugs: new insight and preventive strategies. Curr Opin Crit Care 2001; 7: 384-9.

Shihab FS; Bennett WM; Yi H; Andoh TF.
Expression of vascular endothelial growth factor and its receptors Flt-1 and KDR/Flk-1 in chronic cyclosporine nephroxicity.
Transplantation 2001; 72:164-8.

Valente JF; Dreyer DR; Breda MA; Bennett WM.
Laparoscopic renal denervation for intractable ADPKD-related pain.
Nephrol Dial Transplant 2001; 16: 160.

Zager RA; Andoh T; Bennett WM.
Renal cholesterol accumulation: a durable response after acute and subacute renal insults.
Am J Pathol 2001; 159: 743-52.

Bennett WM
Clash of cultures: nephrologists meet the market economy
Nephrol Dial Transplant 2000 Nov;15(11):1749-50.

Shihab FS; Yi H; Bennett WM; Andoh TF.
Effect of nitric oxide modulation on TGF-beta1 and matrix proteins in chronic cyclosporine nephrotoxicity.
Kidney Int 2000;58:1174-85.